Jasna Markovac

706 total citations
10 papers, 553 citations indexed

About

Jasna Markovac is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jasna Markovac has authored 10 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Health, Toxicology and Mutagenesis and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jasna Markovac's work include Barrier Structure and Function Studies (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Trace Elements in Health (2 papers). Jasna Markovac is often cited by papers focused on Barrier Structure and Function Studies (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Trace Elements in Health (2 papers). Jasna Markovac collaborates with scholars based in United States. Jasna Markovac's co-authors include Gary W. Goldstein, Robert P. Erickson, Margaret E. Gnegy, Subhash C. Datta, Patricia L. Robertson, Virginia Hieber, Larry D. Gruppen, James O. Woolliscroft and Michael Hortsch and has published in prestigious journals such as Nature, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

Jasna Markovac

10 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasna Markovac United States 6 300 198 150 128 40 10 553
Michael F. Hare United States 15 411 1.4× 167 0.8× 159 1.1× 154 1.2× 21 0.5× 21 690
Domenico Vitarella United States 15 314 1.0× 215 1.1× 110 0.7× 178 1.4× 79 2.0× 34 749
Marcey Kern United States 10 135 0.5× 94 0.5× 139 0.9× 128 1.0× 43 1.1× 13 424
S Fuenzalida United States 4 305 1.0× 245 1.2× 53 0.4× 159 1.2× 37 0.9× 8 655
Beata Dąbrowska‐Bouta Poland 19 354 1.2× 178 0.9× 170 1.1× 181 1.4× 60 1.5× 46 980
Wendy Jiang United States 20 327 1.1× 355 1.8× 144 1.0× 150 1.2× 149 3.7× 34 933
Zhaobao Yin United States 11 464 1.5× 316 1.6× 177 1.2× 177 1.4× 47 1.2× 11 866
Stephen H. Reaney United States 11 147 0.5× 134 0.7× 190 1.3× 166 1.3× 180 4.5× 11 756
Fengyuan Piao China 18 243 0.8× 110 0.6× 241 1.6× 95 0.7× 128 3.2× 48 804
Lan Hong China 13 120 0.4× 115 0.6× 116 0.8× 83 0.6× 51 1.3× 21 487

Countries citing papers authored by Jasna Markovac

Since Specialization
Citations

This map shows the geographic impact of Jasna Markovac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasna Markovac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasna Markovac more than expected).

Fields of papers citing papers by Jasna Markovac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasna Markovac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasna Markovac. The network helps show where Jasna Markovac may publish in the future.

Co-authorship network of co-authors of Jasna Markovac

This figure shows the co-authorship network connecting the top 25 collaborators of Jasna Markovac. A scholar is included among the top collaborators of Jasna Markovac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasna Markovac. Jasna Markovac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Woolliscroft, James O., et al.. (2023). Healthcare is not about health. FASEB BioAdvances. 5(6). 221–227. 3 indexed citations
2.
Hortsch, Michael, Jasna Markovac, & James O. Woolliscroft. (2020). Introduction to the special collection on biomedical education. FASEB BioAdvances. 2(11). 629–630. 2 indexed citations
3.
Markovac, Jasna & Gary W. Goldstein. (1988). Picomolar concentrations of lead stimulate brain protein kinase C. Nature. 334(6177). 71–73. 352 indexed citations
4.
Markovac, Jasna & Gary W. Goldstein. (1988). Transforming growth factor beta activates protein kinase C in microvessels isolated from immature rat brain. Biochemical and Biophysical Research Communications. 150(2). 575–582. 35 indexed citations
5.
Markovac, Jasna & Gary W. Goldstein. (1988). Lead activates protein kinase C in immature rat brain microvessels. Toxicology and Applied Pharmacology. 96(1). 14–23. 94 indexed citations
6.
Robertson, Patricia L., Jasna Markovac, Subhash C. Datta, & Gary W. Goldstein. (1988). Transforming growth factor beta stimulates phosphoinositol metabolism and translocation of protein kinase C in cultured astrocytes. Neuroscience Letters. 93(1). 107–113. 30 indexed citations
7.
Markovac, Jasna & Robert P. Erickson. (1985). A component of genetic variation among mice in activity of transmembrane methyltransferase I determined by the H-2 region. Biochemical Pharmacology. 34(19). 3421–3425. 3 indexed citations
8.
Markovac, Jasna & Robert P. Erickson. (1983). Genetic variation in β-adrenergic receptors in mice: A magnesium effect determined by a single gene. Genetics Research. 42(2). 159–168. 2 indexed citations
9.
Gnegy, Margaret E., Robert P. Erickson, & Jasna Markovac. (1981). Increased calmodulin in cultured skin fibroblasts from patients with cystic fibrosis. Biochemical Medicine. 26(3). 294–298. 27 indexed citations
10.
Markovac, Jasna, Robert P. Erickson, & Virginia Hieber. (1981). Increased cyclic AMP levels and β-adrenergic antagonist binding in cystic fibrosis fibroblasts. Biochemical Medicine. 26(3). 299–306. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026